These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 31156083)

  • 1. Sixteen-week versus standard eight-week prednisolone therapy for childhood nephrotic syndrome: the PREDNOS RCT.
    Webb NJ; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Wheatley K; Ives NJ
    Health Technol Assess; 2019 May; 23(26):1-108. PubMed ID: 31156083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT; Webb NJ; Woolley RL; Afentou N; Mehta S; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    Health Technol Assess; 2022 Jan; 26(3):1-94. PubMed ID: 35060851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
    Webb NJA; Woolley RL; Lambe T; Frew E; Brettell EA; Barsoum EN; Trompeter RS; Cummins C; Deeks JJ; Wheatley K; Ives NJ;
    BMJ; 2019 May; 365():l1800. PubMed ID: 31335316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial.
    Webb NJ; Frew E; Brettell EA; Milford DV; Bockenhauer D; Saleem MA; Christian M; Hall AS; Koziell A; Maxwell H; Hegde S; Finlay ER; Gilbert RD; Booth J; Jones C; McKeever K; Cook W; Ives NJ;
    Trials; 2014 Apr; 15():147. PubMed ID: 24767719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D; Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD001533. PubMed ID: 25785660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.
    Larkins NG; Liu ID; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002290. PubMed ID: 32297308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Daily Low-Dose Prednisolone During Upper Respiratory Tract Infection to Prevent Relapse in Children With Relapsing Steroid-Sensitive Nephrotic Syndrome: The PREDNOS 2 Randomized Clinical Trial.
    Christian MT; Webb NJA; Mehta S; Woolley RL; Afentou N; Frew E; Brettell EA; Khan AR; Milford DV; Bockenhauer D; Saleem MA; Hall AS; Koziell A; Maxwell H; Hegde S; Prajapati H; Gilbert RD; Jones C; McKeever K; Cook W; Ives N
    JAMA Pediatr; 2022 Mar; 176(3):236-243. PubMed ID: 34928294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial.
    Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y;
    Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid therapy for nephrotic syndrome in children.
    Hahn D; Samuel SM; Willis NS; Craig JC; Hodson EM
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD001533. PubMed ID: 39171624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2003; (1):CD001533. PubMed ID: 12535410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2004; (2):CD001533. PubMed ID: 15106158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home-based narrowband UVB, topical corticosteroid or combination for children and adults with vitiligo: HI-Light Vitiligo three-arm RCT.
    Batchelor JM; Thomas KS; Akram P; Azad J; Bewley A; Chalmers JR; Cheung ST; Duley L; Eleftheriadou V; Ellis R; Ferguson A; Goulding JM; Haines RH; Hamad H; Ingram JR; Laguda B; Leighton P; Levell N; Makrygeorgou A; Meakin GD; Millington A; Ogboli M; Rajasekaran A; Ravenscroft JC; Rogers A; Sach TH; Santer M; Stainforth J; Tan W; Wahie S; White J; Whitton ME; Williams HC; Wright A; Montgomery AA
    Health Technol Assess; 2020 Nov; 24(64):1-128. PubMed ID: 33245043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07).
    Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K
    BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N; Kim S; Craig J; Hodson E
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2001; (2):CD001533. PubMed ID: 11405997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid therapy for nephrotic syndrome in children.
    Hodson EM; Knight JF; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2000; (4):CD001533. PubMed ID: 11034723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trial.
    Chalmers JR; Wojnarowska F; Kirtschig G; Mason J; Childs M; Whitham D; Harman K; Chapman A; Walton S; Schmidt E; Godec TR; Nunn AJ; Williams HC
    Health Technol Assess; 2017 Mar; 21(10):1-90. PubMed ID: 28406394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.
    Jayne D; Walsh M; Merkel PA; Peh CA; Szpirt W; Puéchal X; Fujimoto S; Hawley C; Khalidi N; Jones R; Flossmann O; Wald R; Girard L; Levin A; Gregorini G; Harper L; Clark W; Pagnoux C; Specks U; Smyth L; Ito-Ihara T; de Zoysa J; Brezina B; Mazzetti A; McAlear CA; Reidlinger D; Mehta S; Ives N; Brettell EA; Jarrett H; Wheatley K; Broadhurst E; Casian A; Pusey CD
    Health Technol Assess; 2022 Sep; 26(38):1-60. PubMed ID: 36155131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT.
    Duffy L; Clarke CS; Lewis G; Marston L; Freemantle N; Gilbody S; Hunter R; Kendrick T; Kessler D; King M; Lanham P; Mangin D; Moore M; Nazareth I; Wiles N; Bacon F; Bird M; Brabyn S; Burns A; Donkor Y; Hunt A; Pervin J; Lewis G
    Health Technol Assess; 2021 Nov; 25(69):1-62. PubMed ID: 34842135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.